|
市場調査レポート
商品コード
1373840
低温プラズマの世界市場規模、シェア、成長分析：条件別、技術別 - 産業予測（2023年～2030年）Global Cold Plasma Market Size, Share, Growth Analysis, By Regime(Low Pressure and Atmospheric Pressure), By Technology(Remote Treatment, Direct Treatment) - Industry Forecast 2023-2030 |
||||||
|
|
|||||||
|
|||||||
| 低温プラズマの世界市場規模、シェア、成長分析：条件別、技術別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月28日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の低温プラズマの市場規模は2021年に16億米ドルとなり、2022年の18億5,000万米ドルから2030年までに68億7,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで15.7%の成長が見込まれています。
市場は、さまざまな産業における多彩な応用範囲により、近年大きな注目と認知を集めています。市場の主な促進要因の1つは、環境に優しく持続可能なソリューションに対する需要の高まりです。低温プラズマ技術は、従来の化学品ベースのプロセスに代わるクリーンで環境に優しい代替技術を提供するため、環境フットプリントの削減に努める産業にとってますます魅力的なものとなっています。さらに、食品の安全性に対する懸念の高まりや、医療施設における効果的な滅菌技術の必要性も、市場の成長に寄与しています。市場では、低温プラズマ技術の応用分野を開発し拡大するための研究開発が盛んに行われています。研究者とメーカーは、低温プラズマの装置およびシステムの効率と有効性の改善に絶えず取り組んでおり、その結果、低温プラズマ採用の新たな道が開かれています。
世界の低温プラズマの市場力学
世界の低温プラズマ市場の促進要因
低温プラズマ技術の利点
低温プラズマ技術は、重要な産業において複数の用途があります。低温プラズマ技術の利点は、水とエネルギーの消費の少なさ、化学品の消費の少なさ、繊維に対する影響の少なさ、低い引火性、高い濡れ性、低いコスト、作業者の使いやすさなどです。低温プラズマ技術は、利用や処理後の洗浄のために化学品を保管する必要がありません。応用部門ですでに使用されている代替技術に対するこの技術の利点は、低温プラズマ技術の導入に重要な役割を果たしました。これらの利点のため、低温プラズマ技術の主な成長促進要因は利用の増加です。
世界の低温プラズマ市場の抑制要因
低温プラズマの限られた商業化
低温プラズマ技術の商業化は過去10年間において限定的でした。低温プラズマが成功を収めている産業はわずかです。生産ユニット数が少ないため、低温プラズマ技術は世界中で広く利用されているわけではありません。低温プラズマ技術の普及が遅れているのは、技術に関する知識が不足しているためです。その結果、低温プラズマの商業化は限られており、市場の拡大を抑制しています。
低温プラズマの世界の動向
医療における採用の拡大
低温プラズマ技術は、創傷治癒、歯科治療、がん治療などのさまざまな用途で医療部門での採用が拡大しています。その抗菌性と組織の再生を促進する能力により、医療分野で有望なツールとなっています。
規制支援
世界中の政府と規制機関は、低温プラズマ技術の可能性を認識し、資金援助、インセンティブ、有利な政策による支援を行っています。このような支援は研究開発活動を促進し、市場の採用を加速します。
当レポートでは、世界の低温プラズマ市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の低温プラズマ市場：条件別
- 市場の概要
- 低圧
- 大気圧
世界の低温プラズマ市場：技術別
- 市場の概要
- 遠隔治療
- 直接治療
- 電極接触
世界の低温プラズマの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Apyx Medical (U.S.)
- Nordson Corporation (U.S.)
- Adtec RF. (Japan)
- P2i Ltd. (U.K.)
- RELYON PLASMA GMBH (Germany)
- Henniker (U.K.)
- Enercon Industries Corporation (U.S.)
- AcXys Technologies (France)
- Plasmatreat GmbH (Germany)
- Tantec (Denmark)
- Europlasma (Belgium)
- Thierry Corp. (U.S.)
- Surfx Technologies, LLC (U.S.)
- SOFTAL Corona & Plasma GmbH (Germany)
- CPI (France)
- Ferrarini & Benelli Srl (Italy)
- neoplas med GmbH (Germany)
- terraplasma GmbH (Germany)
- Molecular Plasma Group (Luxembourg)
- CINOGY (Germany)
Global Cold Plasma Market size was valued at USD 1.60 billion in 2021 and is poised to grow from USD 1.85 billion in 2022 to USD 6.87 billion by 2030, at a CAGR of 15.7% during the forecast period (2023-2030).
The global Cold Plasma market has gained significant attention and recognition in recent years due to its diverse range of applications across various industries. Cold Plasma technology offers several advantages over traditional thermal plasma, including lower operating temperatures, reduced damage to sensitive materials, and the ability to treat surfaces without causing thermal damage. These unique properties make it suitable for a wide array of applications, such as surface treatment, sterilization, wound healing, and food safety. One of the key drivers of the global market is the growing demand for eco-friendly and sustainable solutions. Cold Plasma technology offers a clean and environmentally friendly alternative to conventional chemical-based processes, making it increasingly attractive to industries striving to reduce their environmental footprint. Additionally, the rising concerns over food safety and the need for effective sterilization techniques in healthcare facilities further contribute to the market's growth. The market is witnessing significant research and development activities to explore and expand the applications of Cold Plasma technology. Researchers and manufacturers are constantly working on improving the efficiency and effectiveness of Cold Plasma devices and systems, thus opening up new avenues for its adoption.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cold Plasma Market Segmental Analysis
The global Cold Plasma market is segmented on the basis of regime, technology, and region. By regime, the market is segmented into low pressure and atmospheric pressure. By technology, the market is segmented into Remote Treatment, Direct Treatment, and Electrode Contact. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Cold Plasma Market Dynamics
Drivers of the Global Cold Plasma Market
Benefits of cold plasma technology
There are several uses for cold plasma technology in significant industries. Numerous benefits of cold plasma technology include its low water and energy consumption, low chemical consumption, minimum impact on fibres, decreased flammability, increased wettability, low cost, and worker-friendliness. Cold plasma technologies do not need to store chemicals for this application or in post-treatment washing. The advantages of the technology over the alternatives already used in application sectors had a significant role in the introduction of cold plasma technology. Because of these advantages, a key growth driver for cold plasma technology is the increase in applications.
Restraints in the Global Cold Plasma Market
Limited commercialization of cold plasma
Cold plasma technology has seen limited commercialisation over the past ten years because there are currently only a few players in the industry. There are only a few industries where cold plasma has found success. Due to the small number of production units, cold plasma technology is not widely accessible worldwide. The slower acceptance of cold plasma technology is a result of a lack of knowledge about it. As a result, cold plasma has limited commercialization, which restrains the market's expansion.
Market Trends of Global Cold Plasma Key
Growing Adoption in Healthcare
Cold Plasma technology is witnessing increased adoption in the healthcare sector for various applications, including wound healing, dental treatments, and cancer therapy. Its antimicrobial properties and ability to promote tissue regeneration make it a promising tool in the medical field.
Regulatory Support
Governments and regulatory bodies across the globe are recognizing the potential of Cold Plasma technology and providing support through funding, incentives, and favorable policies. This support encourages research and development activities and accelerates market adoption.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cold Plasma Market by Regime
- Market Overview
- Low Pressure and Atmospheric Pressure
- Global Cold Plasma Market by Technology
- Market Overview
- Remote Treatment
- Direct Treatment
- and Electrode Contact
- Global Cold Plasma Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Apyx Medical (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nordson Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Adtec RF. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- P2i Ltd. (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RELYON PLASMA GMBH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Henniker (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enercon Industries Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AcXys Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Plasmatreat GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tantec (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Europlasma (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thierry Corp. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Surfx Technologies, LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SOFTAL Corona & Plasma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CPI (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferrarini & Benelli Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- neoplas med GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- terraplasma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Molecular Plasma Group (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CINOGY (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
